Tender Details
Description / Scope of Work
The Institute of Blood Transfusion Services Punjab Lahore (IBTS) invites bids for a framework contract to procure thalassemia medicines and blood grouping anti sera under tender inquiry IBTS/MBG/26-27 for the fiscal year 2026-27. The procurement encompasses five lots of essential medical supplies required for blood transfusion and thalassemia treatment services across Punjab. This is a framework contract arrangement, indicating multiple calls-off orders may be placed during the contract period based on operational requirements and budget availability.
Eligible bidders must be registered suppliers capable of supplying pharmaceutical and laboratory products that meet international quality and safety standards. Bidders are required to provide technical documentation establishing goods' conformity to specifications, evidence of manufacturer authorization where applicable, and proof of business registration. A bid security in the form specified in the bidding documents must accompany all submissions, and bidders must demonstrate financial and technical capacity to fulfil framework obligations over the contract period.
Bidding documents are available from the Institute of Blood Transfusion Services, with submission required through the Punjab e-Procurement system in accordance with the specified deadline. Bids will be opened electronically, and technical and financial evaluation will follow preliminary examination of eligibility. Interested bidders should contact IBTS directly for clarification on technical specifications and procurement procedures. Award will be made to the lowest evaluated responsive bidder meeting all qualification criteria and technical requirements.
For Bidders: Our Analysis PAKISTANTENDER INSIGHT
Independent analysis by PakistanTender — not part of the official notice. Always confirm details against the original tender document.
Framework contract for thalassemia medicines and blood grouping anti sera across five lots for FY 2026-27 in Punjab.
This is recurring procurement by a public health institution, indicating stable demand. Suppliers must meet pharmaceutical quality standards and be capable of sustained supply performance. The framework structure suggests multiple small-to-medium orders rather than one large shipment, favouring suppliers with reliable inventory and logistics. No specific quantity or budget stated in available sections, but blood transfusion services procurement is typically medium-scale institutional demand.
Who can bid: Bidders must typically be registered with SECP or equivalent authority, hold valid trade licenses, and provide evidence of pharmaceutical/laboratory product supply experience. Manufacturers' authorization certificates and quality certifications (GMP, ISO, or local regulatory approval) are typically required for medicines and anti sera. PEC registration is not required; however, DRAP or equivalent pharmaceutical authority approval for products is standard.